The Liver Meeting 2022-Hepatitis C SIG Program: Remaining Challenges and Opportunities in Hepatitis C Prevention and Treatment

Hepatitis C SIG Program: Remaining Challenges and Opportunities in Hepatitis C Prevention and Treatment

Video Transcription

Video Summary

The video transcript features two speakers discussing different aspects of addressing hepatitis C. The first speaker, Jennifer Price, discusses the challenges in diagnosing and treating hepatitis C, as well as the barriers to treatment access. She emphasizes the need for point-of-care testing and early initiation of treatment. The second speaker, Julius Wilder, focuses on racial and ethnic disparities in hepatitis C care and highlights the impact of social factors on these disparities. He emphasizes the need to address the root causes of disparities and create sustainable interventions. Overall, the video transcript highlights the need for improved access to testing and treatment for hepatitis C, particularly in underserved communities, and the importance of addressing social and systemic factors that contribute to disparities.

Asset Caption

Despite unprecedented advances in the diagnosis and management of people with hepatitis C virus, substantial challenges remain to the elimination of hepatitis C as a public health threat and the prevention and treatment of hepatitis C virus infection in particular patient populations who remain underserved by current care strategies. In this Hepatitis C SIG program, our experts will discuss the challenges and opportunities to address the threat of hepatitis in people who use drugs, those who are pregnant, and persons who have received disparate care as a result of racial and ethnic inequities.

Keywords

video transcript

hepatitis C

diagnosing

treating

barriers

treatment access

point-of-care testing

racial disparities

ethnic disparities

social factors

underserved communities

improved access

systemic factors